Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Pediatr ; 229: 33-40, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33075369

RESUMEN

OBJECTIVE: To describe the similarities and differences in the evaluation and treatment of multisystem inflammatory syndrome in children (MIS-C) at hospitals in the US. STUDY DESIGN: We conducted a cross-sectional survey from June 16 to July 16, 2020, of US children's hospitals regarding protocols for management of patients with MIS-C. Elements included characteristics of the hospital, clinical definition of MIS-C, evaluation, treatment, and follow-up. We summarized key findings and compared results from centers in which >5 patients had been treated vs those in which ≤5 patients had been treated. RESULTS: In all, 40 centers of varying size and experience with MIS-C participated in this protocol survey. Overall, 21 of 40 centers required only 1 day of fever for MIS-C to be considered. In the evaluation of patients, there was often a tiered approach. Intravenous immunoglobulin was the most widely recommended medication to treat MIS-C (98% of centers). Corticosteroids were listed in 93% of protocols primarily for moderate or severe cases. Aspirin was commonly recommended for mild cases, whereas heparin or low molecular weight heparin were to be used primarily in severe cases. In severe cases, anakinra and vasopressors frequently were recommended; 39 of 40 centers recommended follow-up with cardiology. There were similar findings between centers in which >5 patients vs ≤5 patients had been managed. Supplemental materials containing hospital protocols are provided. CONCLUSIONS: There are many similarities yet key differences between hospital protocols for MIS-C. These findings can help healthcare providers learn from others regarding options for managing MIS-C.


Asunto(s)
COVID-19/terapia , Protocolos Clínicos , Pautas de la Práctica en Medicina/estadística & datos numéricos , Síndrome de Respuesta Inflamatoria Sistémica/terapia , Antiinflamatorios no Esteroideos/uso terapéutico , Anticoagulantes/uso terapéutico , Antirreumáticos/uso terapéutico , Aspirina/uso terapéutico , COVID-19/diagnóstico , Niño , Estudios Transversales , Glucocorticoides/uso terapéutico , Heparina/uso terapéutico , Hospitales , Humanos , Inmunoglobulinas Intravenosas , Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico , Encuestas y Cuestionarios , Síndrome de Respuesta Inflamatoria Sistémica/diagnóstico , Estados Unidos/epidemiología , Vasoconstrictores/uso terapéutico
2.
Eur J Radiol ; 84(10): 1938-42, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26210092

RESUMEN

INTRODUCTION: Right ventricular (RV) size and function in Duchenne muscular dystrophy (DMD) have not been well described. Using cardiac magnetic resonance (CMR) imaging we describe the relationship of RV and left ventricular (LV) size and function in a large DMD cohort. METHODS: Latest CMR scans of 272 patients consecutively seen at a single tertiary referral center (2011-2014) with skeletal muscle biopsy confirmed DMD were included. 1.5 and 3 Tesla CMR scanners were used. Biventricular ejection fraction (EF), end-diastolic volume index (EDVI), mass and mass index were compared across categories of LVEF. RESULTS: Mean age was 13.5 ± 4.9 years. 71% had normal (≥ 55%) LVEF while mild (EF 45-54%), moderate (EF 30-44%), and severe LV dysfunction (EF <30%) was present in 20%, 6% and 3% respectively. The correlation between RVEF and LVEF was weak. Even in patients with severe LV dysfunction, RVEF (49.7% ± 12.9%) was relatively preserved. There were no significant differences in RVEDVI and RV mass index across categories of LV function. CONCLUSION: In a large DMD cohort, RVEF was relatively preserved and RV size was preserved across categories of LV dysfunction.


Asunto(s)
Ventrículos Cardíacos/patología , Distrofia Muscular de Duchenne/fisiopatología , Función Ventricular Izquierda/fisiología , Función Ventricular Derecha/fisiología , Adolescente , Adulto , Volumen Cardíaco/fisiología , Niño , Estudios de Cohortes , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Distrofia Muscular de Duchenne/patología , Tamaño de los Órganos , Volumen Sistólico/fisiología , Disfunción Ventricular Izquierda/fisiopatología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA